Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.71 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.71 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25908923 | 0.99 | CNR1 (0.69) | CNR1GPR55CHRM2ADORA3KCNH2 | |
| SCHEMBL25119022 | 0.97 | CNR1 (0.74) | CNR1GPR55CHRM2ADORA3KCNH2 | |
| SCHEMBL25907895 | 0.96 | CNR1 (0.72) | CNR1GPR55CHRM2ADORA3KCNH2 | |
| SCHEMBL25119288 | 0.87 | CNR1 (0.62) | CNR1GPR55CHRM2ADORA3KCNH2 | |
| SCHEMBL25907887 | 0.84 | CNR1 (0.57) | CNR1GPR55LMNASMN1; SMN2SCN9A | |
| SCHEMBL31090159 | 0.83 | CNR1 (1.00) | CNR1GPR55CHRM2ADORA3KCNH2 | |
| SCHEMBL25907883 | 0.82 | CNR1 (0.54) | CNR1GPR55LMNASMN1; SMN2SCN9A | |
| SCHEMBL25909086 | 0.81 | CNR1 (0.51) | CNR1GPR55LMNASMN1; SMN2SCN9A | |
| SCHEMBL25118979 | 0.81 | CNR1 (0.53) | CNR1GPR55LMNASMN1; SMN2SCN9A | |
| SCHEMBL25502459 | 0.80 | GPR55 (0.69) | CNR1GPR55CHRM2ADORA3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230244147-A1 | COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230244147-A1 | COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM | OR10J3, PYM1, AP1M1 | CNR1 2565/4885GPR55 4460/4885CHRM2 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.